Jade Biosciences Inc.
JBIO | NASDAQ
$13.66
-$0.40 (-2.84%)
Nov 2, 2026, 10:59 AM ET · Market open
Market Data
Market Cap $868.83M
Enterprise Value $433.6M
Beta 1.45
Average Volume 921.61K
Shares Outstanding (Diluted) 61.05M
Shares Change YoY 114.73%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US0080642061
Price Performance
Price Change 1M -3.3%
Price Change 3M -28.7%
Price Change 6M -44.3%
Price Change YTD -11.5%
Price Change 1Y 44.2%
Price Change 3Y -96.6%
Price Change 5Y -97.6%
1M CAGR (ann.) -17.0%
1Y CAGR (ann.) 48.2%
5Y CAGR (ann.) -50.0%
All-Time CAGR -52.9%
Valuation
PE Ratio -5.11
Forward PE N/A
PEG Ratio -0.02
Forward PEG -2.04
PS Ratio N/A
Forward PS N/A
PB Ratio 2.03
P/FCF Ratio -7.24
P/Adj. FCF Ratio -6.18
P/OCF Ratio -6.96
EV/Sales N/A
EV/EBIT -2.77
EV/EBITDA -2.77
EV/FCF -3.51
Earnings Yield -19.6%
FCF Yield -13.8%
Adj. FCF Yield -16.2%
Financial Health
Net Cash $461.21M
Total Debt $628K
Cash & Short-Term Investments $461.21M
Total Assets $472.11M
Current Ratio 14.93
Quick Ratio 14.93
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.01
OCF / Debt -196.67
Interest Coverage 0.00
Altman Z-Score 15.89
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -17.1%
Returns
Return on Assets -32.5%
Return on Equity -49.1%
Return on Invested Capital -37.4%
Return on Capital Employed -37.4%
Return on Tangible Assets -32.5%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 76.2%
EPS CAGR 5Y 7.8%
EPS CAGR 10Y N/A
FCF CAGR 3Y -25.5%
FCF CAGR 5Y -28.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y -0.4%
Revenue Growth Next 3Y N/A
Earnings Date Nov 12, 2026
EPS Estimate (next Q) -$0.73
EPS Growth Est (next Q) 52.1%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $48.40
Price Target Upside 244.2%
Cash Flow
Operating Cash Flow $-123.51M
Free Cash Flow $-123.57M
Adj. Free Cash Flow $-144.67M
FCF Per Share -$2.02
OCF Per Share -$2.02
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-18K
Operating Income $-164.74M
EBITDA $-156.28M
Net Income $-153.24M
EPS (Diluted) -$2.75
Revenue / Employee N/A
Profit / Employee $-2.79M
Employees 55
Add to Watchlist
Select watchlists to add or remove JBIO